CLS Celestica Inc
$302.52
▼ 4.0%Updated Oct 16, 2:25 PM ET
Report Card
CLS at a glance — five pillars scored 0–100 from real filed financials.
How the 0–100 rating is calculatedOverall: Favorable · 63/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
Price — Past Year
▲ Up 120.7% in the year to Jul 6, 2026
Key Metrics
Market Cap
$40.66B
P/E
40.87x
Forward P/E (est.)
29.19x
ROE
47.3%
Revenue Growth
36.7%
EPS Growth
131.2%
Profit Margin
7.0%
FCF Yield
1.1%
Debt / Equity
0.35x
ROIC
33.0%
Interest Coverage
—
Current Ratio
1.23x
Dividend Yield
—
Implied Growth (rev. DCF)
7.8%
Rating Score
63/100
Business Overview
Celestica Inc (CLS) is a large-cap NYSE-listed company in the Electrical Equipment industry, within the Industrials sector, with a market value around $40.66B.
In its latest reported year it generated about $12.39B in revenue and $832.50M in net profit.
Our model rates CLS Favorable (63/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Technical Analysis (Educational)
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what CLS's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. CLS trades near $302.52, below its 50-day average ($380.52) and 200-day average ($318.94). Price below both averages is a downtrend — momentum is against buyers for now.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 38 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.
Volatility — ATR. Average True Range is the typical daily move. CLS's is $24.31 (~8.0% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. In the month to Jul 6, 2026, CLS found buyers near $322.25 (support) and sellers near $414.13 (resistance); its 52-week range then was $152.43–$474.03. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.3× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. The indicators were last computed on Jul 6, 2026; the price is current.
Revenue Growth
3Y CAGR
19.6%
Revenue moved from $7.25B in 2022 to $12.39B in 2025, a 19.6% compound annual growth rate. The most recent year grew a strong 36.7% year over year. Consistent top-line growth is one sign of healthy demand.
Profitability
Gross Margin
12.1%
Operating Margin
8.4%
Net Margin
6.7%
ROE
47.3%
Celestica Inc keeps about 7.0% of each sales dollar as net profit, with a 12.1% gross margin and 8.4% operating margin. Return on equity is 47.3% and return on invested capital about 33.0%. Margins are moderate — typical of a competitive but profitable business.
Debt Analysis
Total Debt
—
Net Debt
—
Net Debt / EBITDA
—
Debt / Equity
0.35x
Leverage: debt-to-equity is 0.4x, with a current ratio of 1.2x. That is a conservative balance sheet — a cushion in downturns.
Cash Flow Analysis
Operating CF
$659.50M
Free Cash Flow
$458.30M
FCF Margin
3.7%
In the latest year Celestica Inc produced about $659.50M of operating cash flow and $458.30M of free cash flow after capital spending. That is a free-cash-flow yield of about 1.1% on today's price. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.
Valuation Analysis
P/E
40.87x
P/S
3.16x
P/B
14.97x
EV / EBITDA
32.99x
CLS trades at 40.9x trailing earnings (about 29.2x on estimated forward earnings), 3.2x sales, and 15.0x book value. Reverse-engineering today's price implies the market expects roughly 7.8% long-term free-cash-flow growth. That is a rich multiple that prices in a lot of future growth.
DCF Fair Value (Educational)
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
How this DCF estimate is calculatedDCF fair value / share
$165.06
Current price
$302.52
Starting FCF (latest 10-K)
$458.30M
Growth, years 1–5
20.0%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Metrics vs. Sector Range
Where CLS sits versus the Industrials companies we cover.
Bands show the middle half (25th–75th percentile) of the 144 Industrials companies in our coverage that have fundamentals data — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
Sector Peer Comparison
How CLS stacks up against its Industrials peers — valuation, profitability, and growth versus the sector median.
Among the 142 rated Industrials companies we cover, CLS ranks #18 by our overall rating. It trades at a premium versus the sector on earnings (40.9x P/E vs. 30.5x median) with a higher return on equity (47.3% vs. 18.1%) and faster revenue growth (36.7% vs. 6.0%).
P/E vs sector
40.9x
median 30.5x
ROE vs sector
47.3%
median 18.1%
Growth vs sector
36.7%
median 6.0%
Sector rank
#18
of 142 rated
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Industrials companies by sub-industry and size, preferring ones with full data. Sector medians and rank use the 142 rated companies among the 273 Industrials stocks we cover. Educational, not a recommendation.
5-Year Projection Model
Project revenue → earnings → price. Edit the assumptions to build your own case.
What drives this projection, and its limits2030 scenario price range (Base Case)
$778.56 – $1,276.84
vs. $302.52 today · implied CAGR 21% – 33%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $16.98B | $23.26B | $31.86B | $43.65B | $59.80B |
| Net income | $1.19B | $1.63B | $2.23B | $3.06B | $4.19B |
| EPS | $8.84 | $12.11 | $16.59 | $22.73 | $31.14 |
| Share price (low) | $221.01 | $302.78 | $414.81 | $568.29 | $778.56 |
| Share price (high) | $362.46 | $496.56 | $680.29 | $932.00 | $1,276.84 |
| CAGR (low–high) | -27% / 20% | 0% / 28% | 11% / 31% | 17% / 32% | 21% / 33% |
Educational scenario model, not a forecast or investment advice. It starts from the latest annual revenue in SEC filings. By default, growth is trailing revenue growth (held between 3% and 45% a year), the net margin is the latest one (held between 3% and 50%, so a loss-making company is modeled with a small profit), and the Base case P/E runs from 60% to 100% of today's. Carrying recent growth forward five years can miss badly in either direction. Outputs are only as good as the assumptions.
Bull Case
The case for CLS:
- Revenue is growing 36.7% a year, a sign of real demand.
- Strong return on equity (47.3%) shows capital is put to work well.
- A conservative balance sheet (debt/equity 0.4x) lowers risk.
- Our model's overall read is Favorable (63/100).
Bear Case
The case against CLS:
- A rich 40.9x earnings multiple prices in a lot of growth.
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Key Risks
Valuation risk — at 40.9x earnings, disappointing results could compress the multiple.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
Investment Thesis
On balance, the fundamentals screen favourably: Celestica Inc is a large-cap industrials business still growing nicely, with modest profitability, and a sound balance sheet. It trades at 40.9x earnings, which our model scores Favorable (63/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Latest SEC Filings
CLS's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen. How to read a 10-K
In the Idea Lab
CLS — frequently asked questions
Is CLS a good stock to buy?
We don't give buy or sell advice. Our model rates Celestica Inc Favorable (63/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is CLS's rating on The Stocks School?
Celestica Inc currently scores 63/100 (Favorable) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does CLS's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Celestica Inc's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for CLS calculated?
It's a scenario model. It starts from the latest annual revenue and net margin in SEC filings, grows revenue at an assumed rate (trailing revenue growth by default), and applies a P/E range built around today's multiple to show the resulting share-price range. When a stock has no growth or P/E data, the starting values are placeholders. It's a tool for thinking, not a prediction.
Is this CLS analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell CLS. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.